For testing MuRF1 inhibitors in a cancer cachexia setting, we injected B16F10 melanoma cells into mouse thighs and monitored melanoma tumor outgrowth until severe cachexia was evident (“Tu mice”). Here, TRIM63 is linked to melanoma.